Insider Trading activities at Salix Pharmaceuticals Ltd (SLXP)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Salix Pharmaceuticals Ltd (SLXP) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Salix Pharmaceuticals Ltd. Table 2 shows the detailed insider transactions. This company's CIK number is 1009356.

Total stock buying since 2014: $0.
Total stock sales since 2014: $18,963,757.
Total stock option exercises since 2014: $3,222,146.


5 insiders reported insider trading activities at Salix Pharmaceuticals Ltd (SLXP):
Insider trading activities of Logan Carolyn J
Insider trading activities of Chappell John F
Insider trading activities of Creech Timothy J
Insider trading activities of Scruggs Rick D
Insider trading activities of Forbes William P

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Salix Pharmaceuticals Ltd (SLXP).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2015 0 $0 71,480 $11,282,847 0 $0
2014 0 $0 65,036 $7,680,910 175,825 $3,222,146

Table 2. Monthly summary of insider trading at Salix Pharmaceuticals Ltd (SLXP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-03 0 $0 71,480 $11,282,847 0 $0
2014-12 0 $0 0 $0 44,000 $775,720
2014-11 0 $0 11,079 $1,053,058 32,450 $571,220
2014-06 0 $0 53,057 $6,532,749 99,375 $1,875,206
2014-05 0 $0 900 $95,103 0 $0

Table 3. Detailed insider trading at Salix Pharmaceuticals Ltd (SLXP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-03-09 Forbes William P (President, Medical R&D and CDO) Sale 42,880 157.84 6,768,179
2015-03-06 Scruggs Rick D (Executive Vice President) Sale 4,000 157.55 630,200
2015-03-06 Forbes William P (EVP Research&Devel & CDO) Sale 20,000 157.96 3,159,200
2015-03-06 Creech Timothy J (See Remarks) Sale 4,600 157.67 725,268
2014-12-22 Logan Carolyn J (President & CEO) Option Ex 44,000 17.63 775,720
2014-11-24 Chappell John F (Director) Option Ex 15,000 17.63 264,450
2014-11-12 Forbes William P (EVP Research&Devel & CDO) Sale 11,079 95.05 1,053,058
2014-11-12 Forbes William P (EVP Research&Devel & CDO) Option Ex 17,450 17.58 306,770
2014-06-26 Logan Carolyn J (President & CEO) Sale 53,057 123.13 6,532,749
2014-06-26 Logan Carolyn J (President & CEO) Option Ex 99,375 18.87 1,875,206
2014-05-16 Scruggs Rick D (Executive Vice President) Sale 900 105.67 95,103

Insider trading activities including stock purchases, stock sales, and option exercises of SLXP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Salix Pharmaceuticals Ltd (symbol SLXP, CIK number 1009356) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.